| Stage | MYRG | % of rev | MCRI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.3B | 100.00% | $146M | 100.00% | MYRG ×8.61 |
| Gross profit | $171M | 13.60% | $82M | 56.33% | MCRI +42.7pp |
| Operating income | $85M | 6.76% | $41M | 28.22% | MCRI +21.5pp |
| Pre-tax income | $82M | 6.54% | $42M | 28.79% | MCRI +22.2pp |
| Net income | $60M | 4.77% | $32M | 21.88% | MCRI +17.1pp |
| Stage | MYRG | MCRI | Gap · A − B |
|---|---|---|---|
| Revenue | $1.3B100.00% | $146M100.00% | MYRG ×8.61 |
| Gross profit | 13.60%$171M | 56.33%$82M | MCRI +42.7pp |
| Operating income | 6.76%$85M | 28.22%$41M | MCRI +21.5pp |
| Pre-tax income | 6.54%$82M | 28.79%$42M | MCRI +22.2pp |
| Net income |
| 4.77%$60M |
| 21.88%$32M |
| MCRI +17.1pp |
No disclosed counterparties: MYRG, MCRI.